This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ares Trading S.a.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: John Gourley: Innovator in Anti-Retroviral Treatments
Introduction
John Gourley is a notable inventor based in Plainville, MA (US). He has made significant contributions to the field of medical treatments, particularly in the area of anti-retroviral therapies for HIV-1.
Latest Patents
Gourley's most recent patent focuses on an innovative approach to treating HIV-1 infected subjects through the administration of growth hormone. This patent outlines methods that may involve co-administration of anti-retroviral therapies (ARTs) or treatment periods without ART. The growth hormone can be administered at a fixed dosage or adjusted over time, showcasing a flexible treatment strategy.
Career Highlights
John Gourley has been instrumental in advancing medical treatments through his research and inventions. His work has the potential to improve the quality of life for individuals living with HIV-1, demonstrating his commitment to innovative healthcare solutions.
Collaborations
Gourley collaborates with talented professionals in his field, including Alena Zalutskaya and Nicolas Chomont. Their combined expertise enhances the development of effective treatment methodologies.
Conclusion
John Gourley's contributions to anti-retroviral treatments highlight his role as an innovator in the medical field. His work continues to pave the way for advancements in HIV-1 treatment strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile